On Thursday, August 28, 2025, the President of the United States issued an Executive Order which effectively disbanded the union...

As artificial intelligence (AI) becomes increasingly embedded in product development and business operations, in-house legal teams are...

This week, the U.S. Patent and Trademark Office (USPTO) issued a memorandum introducing new processes related to discretionary denials of...

This morning, in a likely pro-patent holder approach, the U.S. Patent and Trademark Office (USPTO) rescinded a guidance memorandum from...

A biosimilar is a biologic drug that is highly similar, but not identical, to an already approved biologic drug, i.e. the reference...